Bridion Injection, Solution
Product Images NDC 84549-423

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bridion (NDC 84549-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Propharma Distribution, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (84549 423 12 Label)

This text is a description of Bridion (Sugammadex) Injection, which is for RX use only. Each vial contains 100mg/mL of the injection solution in a 2mL Single Dose Vial. It is intended for intravenous use only and should be protected from light. The vial should be used within 5 days and stored at 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit). The product is manufactured by Egis and packaged by ProPharma Distribution LLC. Additional details such as LOT numbers, expiration dates, and serial numbers are also provided. For full prescribing information, one should refer to the manufacturer's insert.*

FDA Label Image

Chemical Structure (Bridion 01)

FDA Label Image

Chemical Structure (Bridion 02)

FDA Label Image

Figure 1 (Bridion 03)

The given text seems to describe some kind of recovery rate based on time intervals. It includes data related to different substances like sugammadex and neostigmine, along with the time taken for recovery in minutes. It also mentions percentages and observations related to product estimates. Additionally, there are references to cumulative recovery rates and censored observations.*

FDA Label Image

Figure 2 (Bridion 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.